SCHEMBL2829221

SCHEMBL2829221

c1cncc(SSc2cccnc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP2A6 P11509 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 1/20 0.50
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MGLL Q99685 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
APP P05067 1/20 0.39
GAA P10253 1/20 0.39
HCAR3 P49019 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29896037 1.00 ALDH1A1 (0.50) ALDH1A1CYP2A6CYP1A2CYP3A4MEN1
Hydrochloric Acid SCHEMBL30967433 0.97 ALDH1A1 (0.48) ALDH1A1CYP2A6CYP1A2CYP3A4MEN1
Hydrochloric Acid SCHEMBL10942983 0.97 ALDH1A1 (0.48) ALDH1A1CYP2A6CYP1A2CYP3A4MEN1
Ethyne SCHEMBL17596309 0.95 ALDH1A1 (0.46) ALDH1A1CYP2A6CYP1A2CYP3A4MEN1
SCHEMBL14749003 0.85
SCHEMBL25574416 0.85
SCHEMBL9548473 0.83 CYP2A6 (0.50) ALDH1A1CYP2A6CYP1A2CYP3A4MAPT
SCHEMBL16724698 0.82 ALDH1A1 (0.39) ALDH1A1CYP2A6CYP1A2CYP3A4MAPT
SCHEMBL1330059 0.82 EHMT2 (0.63) ALDH1A1CYP2A6CYP1A2CYP3A4MEN1
SCHEMBL585347 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9119307-B2 Housing for a portable electronic device TICONA LLC (US) 2015-08-25 US claimed
WO-2015122941-A1 TOUGHENED POLYARYLENE SULFIDE COMPOSITION TICONA LLC (US) 2015-08-20 WO claimed
WO-2015122942-A1 MOLDED PART FOR USE IN A PORTABLE ELECTRONIC DEVICE TICONA LLC (US) 2015-08-20 WO claimed
US-20150225567-A1 Toughened Polyarylene Sulfide Composition TICONA LLC 2015-08-13 US claimed
US-20150225547-A1 Molded Part for Use in a Portable Electronic Device TICONA LLC 2015-08-13 US claimed
US-20140170415-A1 Multicomponent Fiber Containing a Polyarylene Sulfide TICONA LLC (US) 2014-06-19 US claimed
US-20130249357-A1 Housing for a Portable Electronic Device TICONA LLC (US) 2013-09-26 US claimed
WO-2013052269-A2 HOUSING FOR A PORTABLE ELECTRONIC DEVICE TICONA LLC (US) 2013-04-11 WO claimed
US-20260042903-A1 Laser Transmissive Polyarylene Sulfide Composition TICONA LLC (US) 2026-02-12 US disclosed
US-20260045417-A1 Film Capacitor Containing A Polyarylene Sulfide TICONA LLC (US) 2026-02-12 US disclosed
EP-4662727-A1 NONAQUEOUS ELECTROCHEMICAL BATTERY CONTAINING A SEALING MEMBER Ticona LLC (US) 2025-12-17 EP disclosed
EP-4626953-A1 HYDROLYTICALLY STABLE POLYARYLENE SULFIDE COMPOSITION Ticona LLC (US) 2025-10-08 EP disclosed
US-20250289956-A1 Polymer Composition With Improved Thermal Shock Resistance TICONA LLC 2025-09-18 US disclosed
US-20250250422-A1 Polyarylene Sulfide Composition With Improved Crystallization Properties TICONA LLC 2025-08-07 US disclosed
EP-0111281-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-06-06 EP disclosed
US-4820801-A HIGH PURITY; FOR ELECTRONIC COATINGS OR ENCAPSULATION TOSOH CORP. (JP) 1989-04-11 US disclosed
US-4719206-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-01-12 US disclosed
EP-0225471-A1 Polyphenylene sulfide containing covalently bonded chlorine in a reduced amount and process for producing the same Tosoh Corporation (JP) 1987-06-16 EP disclosed
US-4584290-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-22 US disclosed
EP-0111281-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042903-A1 Laser Transmissive Polyarylene Sulfide Composition TRPC5, TRPC3, TRPC7 ALDH1A1 3998/4885CYP2A6 4246/4885CYP1A2 3488/4885
US-20260045417-A1 Film Capacitor Containing A Polyarylene Sulfide SLC39A3, SLC39A11, SLC39A14 ALDH1A1 3715/4885CYP2A6 3935/4885CYP1A2 2316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.